# Boston Scientific Takes $1.5B, 34% Stake in MiRus for Biomaterials and Implantable Cardiovascular and Orthopedic Devices

> ma · REPORTED · 2026-05-18

Boston Scientific announced a $1.5 billion investment for a 34% stake in MiRus, a company developing biomaterials, implants, and procedural solutions for cardiovascular and orthopedic diseases, including the Siegel balloon expandable TAVR. The deal, announced May 18, 2026, signals major strategic expansion by Boston Scientific into next-generation implantable device platforms.

About Boston Scientific: MiRus is a medical device company developing novel biomaterial-based implants and procedural solutions targeting cardiovascular and orthopedic disease indications.

- Company: Boston Scientific
- Sector: medical devices
- Primary source: https://www.mpo-mag.com/exclusives/2026-medical-device-industry-ma-roundup/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.